Vabiotech: Clinical Trials

4 trials sponsored by Vabiotech, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Unknown 1
Phase 42Completed 2

Follow Vabiotech: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age
PNEUMOSIL® - Streptococcus Pneumonia, Vaccine Preventable Disease
Not applicableUnknownVabiotech3002022-01-252021-12-01
Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old
Skyvaricella Injection - Chickenpox
Phase 4CompletedVietnam Military Medical University2012021-04-172023-07-06
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
RABIVAX-S - Rabies
Phase 4CompletedVietnam Military Medical University2202020-06-132023-07-20
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval - Diphtheria, Tetanus
Not applicableCompletedVabiotech2222018-03-012019-05-03

Conditions studied

Chickenpox (1)  ·  Diphtheria (1)  ·  Haemophilus Infections (1)  ·  Hepatitis B (1)  ·  Pneumonia (1)  ·  Rabies (1)  ·  Tetanus (1)  ·  Vaccine-Preventable Diseases (1)  ·  Whooping Cough (1)

Countries

Vietnam (3)

Top investigators

Pham N Hung, As. Prof. (2)  ·  Son T Vu, PhD (1)

Results publications

PMID 39927222, PMID 42042812